Industry News
Pharmaceutical Industry News

AbbVie runs first Qulipta TV ad spots as it focuses on what you ‘can control inside’
AbbVie runs first Qulipta TV ad spots as it focuses on what you ‘can control inside’ badams Fri, 02/11/2022 - 06:27
Eli Lilly talks up ‘long-term’ game plan for tirzepatide launch, but don’t expect major sales early on
Eli Lilly talks up ‘long-term’ game plan for tirzepatide launch, but don’t expect major sales early on badams Fri, 02/11/2022 - 04:11
FDA Panel Rejects Lilly’s Cancer Drug Tested Only in China
The panel debated whether overseas trials could be applied to a more diverse U.S. population. The decision may affect other Chinese drug trials, and spotlights the high cost of immunotherapy.
Thumbs down on Lilly, Innovent China trial for lung cancer drug Tyvyt, says FDA AdComm
Thumbs down on Lilly, Innovent China trial for lung cancer drug Tyvyt, says FDA AdComm kdunleavy Thu, 02/10/2022 - 15:54
Biogen, Eisai strike back against CMS’ stifling Aduhelm coverage proposal
Biogen, Eisai strike back against CMS' stifling Aduhelm coverage proposal fkansteiner Thu, 02/10/2022 - 13:10
Eli Lilly promises 40% discount for Innovent’s PD-1 in last-ditch bid to shift FDA review to drug pricing
Eli Lilly promises 40% discount for Innovent’s PD-1 in last-ditch bid to shift FDA review to drug pricing aliu Thu, 02/10/2022 - 11:32
FDA nominee Califf pledges to enforce accelerated approval mandates as he jockeys for Senate support
FDA nominee Califf pledges to enforce accelerated approval mandates as he jockeys for Senate support fkansteiner Thu, 02/10/2022 - 11:02
AstraZeneca’s COVID vaccine sales reached $4B last year, but don’t expect that much in 2022
AstraZeneca's COVID vaccine sales reached $4B last year, but don't expect that much in 2022 kdunleavy Thu, 02/10/2022 - 10:10
Hologic goes big with Mary J. Blige at the Super Bowl
Hologic goes big with Mary J. Blige at the Super Bowl sharon.coey Thu, 02/10/2022 - 09:53
Elanco completes sale of a pair of plants to CDMO TriRx in Kansas and UK
Elanco completes sale of a pair of plants to CDMO TriRx in Kansas and UK jkeenan Thu, 02/10/2022 - 09:39
AstraZeneca R&D chiefs talk roxadustat trial, Ultomiris threats and Imfinzi wingman treme’s future
AstraZeneca R&D chiefs talk roxadustat trial, Ultomiris threats and Imfinzi wingman treme’s future aliu Thu, 02/10/2022 - 09:17
C.D.C. Proposes New Guidelines for Treating Pain, Including Opioid Use
The agency threw out previous recommended limits on doses but encouraged “nonopioid therapies” wherever possible.
Teva CEO says company could pay up to $3.6B to put opioid litigation to bed: report
Teva CEO says company could pay up to $3.6B to put opioid litigation to bed: report fkansteiner Thu, 02/10/2022 - 08:48
Skyepharma inks deal to build largest microbiome facility in France
Skyepharma inks deal to build largest microbiome facility in France jkeenan Thu, 02/10/2022 - 08:42
American Lung Association campaign, backed by pharma, tackles lack of diversity in lung cancer trials
American Lung Association campaign, backed by pharma, tackles lack of diversity in lung cancer trials nmissakian Thu, 02/10/2022 - 08:42
Seagen, Genmab run ‘CeMe’ cervical cancer campaign amid Tivdak launch
Seagen, Genmab run ‘CeMe’ cervical cancer campaign amid Tivdak launch badams Thu, 02/10/2022 - 06:38
Angry Customers, More Work and Longer Hours Strain Pharmacists
Pharmacists and technicians, who have played a critical role in administering Covid-19 tests and vaccines, say they are burned out nearly two years into the pandemic.
AbbVie’s Qulipta gains ground with docs for migraine prevention, as pharma looks to pressure Biohaven’s Nurtec
AbbVie’s Qulipta gains ground with docs for migraine prevention, as pharma looks to pressure Biohaven’s Nurtec badams Thu, 02/10/2022 - 04:45
House Republicans, advocacy groups urge HHS to abandon measure that would restrict coverage of Biogen’s Aduhelm
House Republicans, advocacy groups urge HHS to abandon measure that would restrict coverage of Biogen's Aduhelm kdunleavy Wed, 02/09/2022 - 15:58
The Next Vaccine Debate: Immunize Young Children Now, or Wait?
It’s not clear whether three doses of the Pfizer-BioNTech vaccine will adequately protect young children. But the F.D.A. may authorize the first two doses anyway.


